GLAB — Gemina Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- CA$36.66m
- CA$37.16m
2021 January 31st | 2022 January 31st | 2023 January 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 0.898 | 1.17 | 0.083 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.004 | 0.178 | 0.386 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 2.45 | 1.38 | 0.563 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.046 | 0.041 | 0.318 |
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 2.53 | 1.42 | 1.87 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 2.33 | 0.47 | 1.75 |
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Liabilities | 2.37 | 0.476 | 1.95 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 0.16 | 0.944 | -0.072 |
Total Liabilities & Shareholders' Equity | 2.53 | 1.42 | 1.87 |
Total Common Shares Outstanding |